Hematopoietic cell-specific lyn substrate (HCLS1 or HS1): A versatile actin-binding protein in leukocytes.

Autor: Castro-Ochoa KF; Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico., Guerrero-Fonseca IM; Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico., Schnoor M; Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico.
Jazyk: angličtina
Zdroj: Journal of leukocyte biology [J Leukoc Biol] 2019 May; Vol. 105 (5), pp. 881-890. Date of Electronic Publication: 2018 Dec 11.
DOI: 10.1002/JLB.MR0618-212R
Abstrakt: Leukocytes are constantly produced in the bone marrow and released into the circulation. Many different leukocyte subpopulations exist that exert distinct functions. Leukocytes are recruited to sites of inflammation and combat the cause of inflammation via many different effector functions. Virtually all of these processes depend on dynamic actin remodeling allowing leukocytes to adhere, migrate, phagocytose, and release granules. However, actin dynamics are not possible without actin-binding proteins (ABP) that orchestrate the balance between actin polymerization, branching, and depolymerization. The homologue of the ubiquitous ABP cortactin in hematopoietic cells is hematopoietic cell-specific lyn substrate-1, often called hematopoietic cell-specific protein-1 (HCLS1 or HS1). HS1 has been reported in different leukocytes to regulate Arp2/3-dependent migration. However, more evidence is emerging that HS1 functions go far beyond just being a direct actin modulator. For example, HS1 is important for the activation of GTPases and integrins, and mediates signaling downstream of many receptors including BCR, TCR, and CXCR4. In this review, we summarize current knowledge on HS1 functions and discuss them in a pathophysiologic context.
(©2018 Society for Leukocyte Biology.)
Databáze: MEDLINE
Externí odkaz: